Trials / Recruiting
RecruitingNCT06965166
Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
Pilot Prospective Study of Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients with rectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PCD-CT | Participants undergo PCD-CT scan on study |
Timeline
- Start date
- 2024-10-07
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-05-11
- Last updated
- 2025-10-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06965166. Inclusion in this directory is not an endorsement.